Exosens SAS (EXENS)

Currency in EUR
43.10
+1.70(+4.11%)
Closed·
EXENS Scorecard
Full Analysis
Net income is expected to grow this year
EXENS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42.2044.25
52 wk Range
16.8446.60
Key Statistics
Prev. Close
41.4
Open
42.2
Day's Range
42.2-44.25
52 wk Range
16.84-46.6
Volume
176.75K
Average Volume (3m)
113.26K
1-Year Change
106.74%
Book Value / Share
8.46
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXENS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
41.21
Downside
-4.38%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Exosens SAS News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Exosens SAS Company Profile

Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions. It operates under the Photonis, Xenics, Telops, and El-Mul brand names. The company serves defense and surveillance, industrial research and control, life science and environment, and nuclear markets. The company was founded in 1937 and is based in Mérignac, France. Exosens operates as a subsidiary of HLD Europe S.C.A.

Employees
1900
Market
France

Exosens SAS Earnings Call Summary for Q4/2024

  • Exosens reported 35% YoY revenue growth to €394M in Q4 2024, with stock surging 15.47% pre-market
  • Net profit increased 66% YoY to €30.7M; company announced first-ever dividend of €0.1 per share
  • EBITDA reached €118.5M with 30.1% margin; leverage ratio improved to 1.2x from 3.3x
  • Management projects high-teens revenue growth and low 20s EBITDA growth for 2025
  • Company expanding capacity in US and Europe, pursuing selective M&A to enhance technological capabilities
Last Updated: 03/03/2025, 10:10
Read Full Transcript

Compare EXENS to Peers and Sector

Metrics to compare
EXENS
Peers
Sector
Relationship
P/E Ratio
43.3x34.1x12.5x
PEG Ratio
-0.160.03
Price/Book
5.1x3.9x1.4x
Price / LTM Sales
5.1x1.6x1.2x
Upside (Analyst Target)
−8.5%11.3%17.9%
Fair Value Upside
Unlock−5.9%7.2%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 41.21
(-4.38% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
0.24%
Industry Median 1.20%
Annualised payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
-- / --
Revenue / Forecast
119.40M / 119.50M
EPS Revisions
Last 90 days

EXENS Income Statement

People Also Watch

236.50
TCFP
+0.42%
256.20
ESLX
+0.35%
27.94
DAST
0.00%
38.76
TE
+1.31%
29.55
VIE
+0.89%

FAQ

What Stock Exchange Does Exosens Trade On?

Exosens is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Exosens?

The stock symbol for Exosens is "EXENS."

What Is the Exosens Market Cap?

As of today, Exosens market cap is 2.10B.

What Is Exosens's Earnings Per Share (TTM)?

The Exosens EPS (TTM) is 0.00.

When Is the Next Exosens Earnings Date?

Exosens will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is EXENS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Exosens Stock Split?

Exosens has split 0 times.

How Many Employees Does Exosens Have?

Exosens has 1900 employees.

What is the current trading status of Exosens (EXENS)?

As of 04 Aug 2025, Exosens (EXENS) is trading at a price of 43.10, with a previous close of 41.40. The stock has fluctuated within a day range of 42.20 to 44.25, while its 52-week range spans from 16.84 to 46.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.